Extensive amyloid formation in transplanted microencapsulated mouse and human islets

Amyloid

Volumn 19, Issue 2, 2012, Pages 87-93

  Bohman, Sara ^a   Westermark, Gunilla T ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Alginate; IAPP; Islet amyloid; Islet amyloid polypeptide; Islet transplantation; Microencapsulation

Indexed keywords

ALGINIC ACID; AMYLIN; AMYLOID; GLUCOSE;

ANIMAL EXPERIMENT; ARTICLE; AUTOPHAGOSOME; ELECTRON MICROSCOPY; FEMALE; HORMONE RELEASE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INSULIN RELEASE; KIDNEY CAPSULE; MALE; MICROENCAPSULATION; MOUSE; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ADULT; AGED; ALGINATES; ANIMALS; CULTURE MEDIA; FEMALE; GLUCOSE; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; INSULIN; INSULIN-SECRETING CELLS; ISLET AMYLOID POLYPEPTIDE; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICE; MICE, INBRED C57BL; MICE, NUDE; MICE, TRANSGENIC; MIDDLE AGED; PLAQUE, AMYLOID; TISSUE CULTURE TECHNIQUES;

EID: 84861607456     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129.2012.679988     Document Type: Article

References (40)

1. Westermark P, Wernstedt C, Wilander E, Sletten K. A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun 1986;140:827-831.
2. Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA 1987;84:3881-3885.
3. Lukinius A, Wilander E, Westermark GT, Engstrom U, Westermark P. Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets. Diabetologia 1989;32:240-244.
4. Kahn SE, D'Alessio DA, Schwartz MW, Fujimoto WY, Ensinck JW, Taborsky GJ Jr, Porte D Jr. Evidence of cosecretion of islet amyloid polypeptide and insulin by β-cells. Diabetes 1990;39:634-638.
5. Janson J, Ashley RH, Harrison D, McIntyre S, Butler PC. The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes 1999;48:491-498.
6. Mirzabekov TA, Lin MC, Kagan BL. Pore formation by the cytotoxic islet amyloid peptide amylin. J Biol Chem 1996;271:1988-1992.
7. Westermark P, Engstrom U, Johnson KH, Westermark GT, Betsholtz C. Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci USA 1990;87:5036-5040.
8. Westermark GT, Gebre-Medhin S, Steiner DF, Westermark P. Islet amyloid development in a mouse strain lacking endogenous islet amyloid polypeptide (IAPP) but expressing human IAPP. Mol Medicine 2000;6:998-1007.
9. Verchere CB, D'Alessio DA, Palmiter RD, Weir GC, Bonner-Weir S, Baskin DG, Kahn SE. Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic β cell expression of human islet amyloid polypeptide. Proc Natl Acad Sci USA 1996;93:3492-3496.
10. Hoppener JW, Oosterwijk C, Nieuwenhuis MG, Posthuma G, Thijssen JH, Vroom TM, Ahren B, Lips CJ. Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model. Diabetologia 1999;42:427-434.
11. Westermark P. Quantitative studies on amyloid in the islets of Langerhans. Ups J Med Sci 1972;77:91-94.
12. Clark A, Charge SB, Badman MK, de Koning EJ. Islet amyloid in type 2 (non-insulin-dependent) diabetes. APMIS 1996;104:12-18.
13. Westermark P, Andersson A, Westermark GT. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol Rev 2011;91:795-826.
14. Westermark P. Amyloid in the islets of Langerhans: thoughts and some historical aspects. Ups J Med Sci 2011;116:81-89.
15. Ward WK, LaCava EC, Paquette TL, Beard JC, Wallum BJ, Porte D Jr. Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 1987;30:698-702.
16. Zheng X, Ren W, Zhang S, Liu J, Li S, Li J, Yang P, et al. Serum levels of proamylin and amylin in normal subjects and patients with impaired glucose regulation and type 2 diabetes mellitus. Acta Diabetol 2010;47:265-270.
17. Paulsson JF, Westermark GT. Aberrant processing of human proislet amyloid polypeptide results in increased amyloid formation. Diabetes 2005;54:2117-2125.
18. Paulsson JF, Andersson A, Westermark P, Westermark GT. Intracellular amyloid-like deposits contain unprocessed pro-islet amyloid polypeptide (proIAPP) in β cells of transgenic mice overexpressing the gene for human IAPP and transplanted human islets. Diabetologia 2006;49:1237-1246.
19. Westermark GT, Davalli AM, Secchi A, Folli F, Kin T, Toso C, Shapiro AM, et al. Further evidence for amyloid deposition in clinical pancreatic islet grafts. Transplantation 2011;93:219-223.
20. Westermark GT, Westermark P, Berne C, Korsgren O; Nordic Network for Clinical Islet Transplantation. Widespread amyloid deposition in transplanted human pancreatic islets. N Engl J Med 2008;359:977-979.
21. Mattsson G, Jansson L, Carlsson PO. Decreased vascular density in mouse pancreatic islets after transplantation. Diabetes 2002;51:1362-1366.
22. King A, Sandler S, Andersson A, Hellerström C, Kulseng B, Skjåk-Braek G. Glucose metabolism in vitro of cultured and transplanted mouse pancreatic islets microencapsulated by means of a high-voltage electrostatic field. Diabetes Care 1999;22 Suppl 2:B121-B126.
23. Puchtler H, Sweat F. Congo red as a stain for fluorescence microscopy of amyloid. J Histochem Cytochem 1965;13:693-694.
24. Christmanson L, Betsholtz C, Leckström A, Engström U, Cortie C, Johnson KH, Adrian TE, Westermark P. Islet amyloid polypeptide in the rabbit and European hare: studies on its relationship to amyloidogenesis. Diabetologia 1993;36:183-188.
25. Bohman S, Waern I, Andersson A, King A. Transient beneficial effects of exendin-4 treatment on the function of microencapsulated mouse pancreatic islets. Cell Transplant 2007;16:15-22.
26. Andersson A. Isolated mouse pancreatic islets in culture: effects of serum and different culture media on the insulin production of the islets. Diabetologia 1978;14:397-404.
27. Verchere CB, D'Alessio DA, Prigeon RL, Hull RL, Kahn SE. The constitutive secretory pathway is a major route for islet amyloid polypeptide secretion in neonatal but not adult rat islet cells. Diabetes 2000;49:1477-1484.
28. Bohman S, King AJ. Islet a cell number is maintained in microencapsulated islet transplantation. Biochem Biophys Res Commun 2008;377:729-733.
29. Novials A, Sarri Y, Casamitjana R, Rivera F, Gomis R. Regulation of islet amyloid polypeptide in human pancreatic islets. Diabetes 1993;42:1514-1519.
30. Zraika S, Hull RL, Udayasankar J, Utzschneider KM, Tong J, Gerchman F, Kahn SE. Glucose- and time-dependence of islet amyloid formation in vitro. Biochem Biophys Res Commun 2007;354:234-239.
31. de Koning EJ, Morris ER, Hofhuis FM, Posthuma G, Höppener JW, Morris JF, Capel PJ, et al. Intra- and extracellular amyloid fibrils are formed in cultured pancreatic islets of transgenic mice expressing human islet amyloid polypeptide. Proc Natl Acad Sci USA 1994;91:8467-8471.
32. Duvivier-Kali VF, Omer A, Parent RJ, O'Neil JJ, Weir GC. Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane. Diabetes 2001;50:1698-1705.
33. CHANG TM. Semipermeable microcapsules. Science 1964;146:524-525.
34. Lim F, Sun AM. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980;210:908-910.
35. de Koning EJ, van den Brand JJ, Mott VL, Chargé SB, Hansen BC, Bodkin NL, Morris JF, Clark A. Macrophages and pancreatic islet amyloidosis. Amyloid 1998;5:247-254.
36. Yamamoto A, Simonsen A. The elimination of accumulated and aggregated proteins: a role for aggrephagy in neurodegeneration. Neurobiol Dis 2011;43:17-28.
37. Verchere CB, D'Alessio DA, Wang S, Andrikopoulos S, Kahn SE. Transgenic overproduction of islet amyloid polypeptide (amylin) is not sufficient for islet amyloid formation. Horm Metab Res 1997;29:311-316.
38. Höppener JW, Jacobs HM, Wierup N, Sotthewes G, Sprong M, de Vos P, Berger R, et al. Human islet amyloid polypeptide transgenic mice: in vivo and ex vivo models for the role of hIAPP in type 2 diabetes mellitus. Exp Diabetes Res 2008;2008:697035.
39. Daval M, Bedrood S, Gurlo T, Huang CJ, Costes S, Butler PC, Langen R. The effect of curcumin on human islet amyloid polypeptide misfolding and toxicity. Amyloid 2010;17:118-128.
40. Frydman-Marom A, Shaltiel-Karyo R, Moshe S, Gazit E. The generic amyloid formation inhibition effect of a designed small aromatic β-breaking peptide. Amyloid 2011;18:119-127.